United States 119th Congress Status: In Committee Bipartisan · 18 D · 1 I cosponsors

S 4355 — Drug Deal Disclosure Act

Last action — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced April 21, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 19 sponsors

    1 primary, 18 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (18 D · 1 I) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

The Drug Deal Disclosure Act aims to improve transparency in the pharmaceutical industry by requiring drug companies to provide clearer information about their pricing and sales practices. This legislation is currently being reviewed by a committee that focuses on health and labor issues.

Bill Text

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 18 co-sponsors · 528 not signed on

Sponsors (1)

Co-sponsors (18)

Not signed on (528)

528 members have not signed on to this bill.

Show all 528 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S 4355 do?
The Drug Deal Disclosure Act aims to improve transparency in the pharmaceutical industry by requiring drug companies to provide clearer information about their pricing and sales practices. This legislation is currently being reviewed by a committee that focuses on health and labor issues.
Who sponsors S 4355?
S 4355 is sponsored by Welch, Peter (Democratic), Warren, Elizabeth (Democratic), Gallego, Ruben (Democratic), Merkley, Jeff (Democratic), Luján, Ben Ray (Democratic), Baldwin, Tammy (Democratic), Whitehouse, Sheldon (Democratic), Kelly, Mark (Democratic), Sanders, Bernard (Independent), Warner, Mark R. (Democratic), Smith, Tina (Democratic), Hassan, Margaret Wood (Democratic), Cortez Masto, Catherine (Democratic), Bennet, Michael F. (Democratic), Warnock, Raphael G. (Democratic), Hirono, Mazie K. (Democratic), Cantwell, Maria (Democratic), Van Hollen, Chris (Democratic), and Wyden, Ron (Democratic).
What is the current status of S 4355?
This bill is in committee in the Senate. Introduced April 21, 2026. It must pass committee before a floor vote.
Where can I track S 4355?
Track S 4355 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 4355

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 4355

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →